Clinical Trials Arena February 13, 2024
Two FDA representatives FDA spoke at the ongoing 2024 SCOPE Summit about how the agency is focusing on AI.
The US Food and Drug Administration (FDA) is focusing on how artificial intelligence (AI) can be used to support clinical trials but says it will take time to get there, as per a regulatory official speaking at the SCOPE Summit.
The role of AI and ML was at the centre of a fireside chat taking place on the third day of the Summit in Orlando, which has been a gathering point for those in the clinical trial strategy and operations field.
Marsha Samson, who works in the CDER office focusing on AI and machine learning (ML) said trial sponsors have told...
Today's Sponsors
Today's Sponsor